Junqin He

2.1k total citations
31 papers, 1.0k citations indexed

About

Junqin He is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Junqin He has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Junqin He's work include Lung Cancer Treatments and Mutations (8 papers), HER2/EGFR in Cancer Research (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). Junqin He is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), HER2/EGFR in Cancer Research (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). Junqin He collaborates with scholars based in United States, Switzerland and Australia. Junqin He's co-authors include Isaiah J. Fidler, Sun-Jin Kim, Robert R. Langley, Dominic Fan, Sertaç Yazıcı, Seung Wook Kim, Marva Maya, Rachel Tsan, Premal H. Thaker and Kenji Yokoi and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Clinical Cancer Research.

In The Last Decade

Junqin He

29 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junqin He United States	15	481	480	412	193	140	31	1.0k
Frank C. Cackowski United States	18	567 1.2×	552 1.1×	319 0.8×	307 1.6×	59 0.4×	41	1.2k
Shi Chang United States	7	261 0.5×	484 1.0×	404 1.0×	205 1.1×	156 1.1×	9	904
Yawei Yuan China	22	398 0.8×	600 1.3×	343 0.8×	372 1.9×	61 0.4×	73	1.2k
Olivera Grbovic-Huezo United States	7	373 0.8×	652 1.4×	180 0.4×	131 0.7×	94 0.7×	8	950
Ruoqian Shen United States	18	442 0.9×	593 1.2×	551 1.3×	283 1.5×	43 0.3×	27	1.2k
Satoshi Kiyama Japan	16	324 0.7×	599 1.2×	199 0.5×	329 1.7×	64 0.5×	36	1.0k
Emmanuel Chautard France	18	274 0.6×	515 1.1×	171 0.4×	204 1.1×	248 1.8×	39	900
Dean B. Reardon United States	18	595 1.2×	791 1.6×	315 0.8×	232 1.2×	75 0.5×	23	1.4k
Tiffany M. Phillips United States	8	903 1.9×	817 1.7×	214 0.5×	436 2.3×	72 0.5×	11	1.5k
Laura G.M. Daenen Netherlands	14	679 1.4×	612 1.3×	192 0.5×	424 2.2×	135 1.0×	30	1.3k

Countries citing papers authored by Junqin He

Since Specialization

Citations

This map shows the geographic impact of Junqin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqin He more than expected).

Fields of papers citing papers by Junqin He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqin He. The network helps show where Junqin He may publish in the future.

Co-authorship network of co-authors of Junqin He

This figure shows the co-authorship network connecting the top 25 collaborators of Junqin He. A scholar is included among the top collaborators of Junqin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqin He. Junqin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Yan, Monique B. Nilsson, Xiaoxing Yu, et al.. (2025). The Activity of EGFR CAR NK and CAR T Cells against EGFR Inhibitor–Resistant NSCLC and Drug-Tolerant Persister Cells. Clinical Cancer Research. 31(22). 4745–4762. 1 indexed citations

Li, Xianrui, et al.. (2025). Ginsenoside Rb1 combined with Lycium barbarum polysaccharide alleviate the Tripterygium wilfordii polyglycoside-induced oligoasthenozoospermia in mice by inhibiting ZnT3-mediated oxidative stress response. Journal of Trace Elements in Medicine and Biology. 89. 127646–127646. 1 indexed citations

Shibata, Yuji, Monique B. Nilsson, Hibiki Udagawa, et al.. (2025). Abstract 7220: Zongertinib demonstrates potent efficacy against cancer cells harboring HER2 non-tyrosine kinase domain mutations. Cancer Research. 85(8_Supplement_1). 7220–7220.

Nilsson, Monique B., Zineb Mounir, Luna Musib, et al.. (2024). Abstract 1964: Furmonertinib is a brain-penetrant EGFR TKI highly active in uncommon EGFR mutations, including PACC and exon 20 insertions. Cancer Research. 84(6_Supplement). 1964–1964.

Udagawa, Hibiki, Monique B. Nilsson, Jacqulyne Robichaux, et al.. (2023). HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies. Journal of Thoracic Oncology. 19(1). 106–118. 9 indexed citations

Lee, Ho Jeong, Masaki Hanibuchi, Sun-Jin Kim, et al.. (2016). Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel. Neuro-Oncology. 18(4). 486–496. 44 indexed citations

Kim, Sun-Jin, Ho Jeong Lee, Hyun Jin Choi, et al.. (2015). Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice. Clinical Cancer Research. 21(20). 4630–4641. 50 indexed citations

Kim, Seung Wook, Hyun Jin Choi, Ho-Jeong Lee, et al.. (2014). Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells. Neuro-Oncology. 16(12). 1585–1598. 76 indexed citations

Lee, Ho-Jeong, John Papadopoulos, Seung Wook Kim, et al.. (2012). Targeted Antivascular Therapy with the Apolipoprotein(a) Kringle V, rhLK8, Inhibits the Growth and Metastasis of Human Prostate Cancer in an Orthotopic Nude Mouse Model. Neoplasia. 14(4). 335–343. 11 indexed citations

10.

Kim, Sun-Jin, Seung Wook Kim, Seok Joong Yun, et al.. (2012). Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist. Translational Oncology. 5(1). 39–47. 30 indexed citations

11.

Kim, Sun-Jin, Jang-Seong Kim, Eun Sung Park, et al.. (2011). Astrocytes Upregulate Survival Genes in Tumor Cells and Induce Protection from Chemotherapy. Neoplasia. 13(3). 286–298. 200 indexed citations

12.

Kim, Sun-Jin, Seung Wook Kim, Emily C. Brantley, et al.. (2011). Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer. Neoplasia. 13(2). 167–IN12. 43 indexed citations

13.

Kim, Seung Wook, John Papadopoulos, Hyun Jin Choi, et al.. (2011). Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse. International Immunopharmacology. 11(7). 862–872. 44 indexed citations

14.

Kim, Sun Jin, Jang‐Seong Kim, Eun Sung Park, et al.. (2010). Abstract 3428: Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Cancer Research. 70(8_Supplement). 3428–3428. 3 indexed citations

15.

Kim, Sun Jin, et al.. (2007). Tumor associated macrophages enhance the establishment and growth of prostate cancer bone metastasis. Cancer Research. 67. 2458–2458. 1 indexed citations

16.

Busby, J. Erik, Sun-Jin Kim, Sertaç Yazıcı, et al.. (2006). Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cells. The Prostate. 66(16). 1788–1798. 23 indexed citations

17.

Kim, Sun-Jin, Hisanori Uehara, Sertaç Yazıcı, et al.. (2006). Targeting Platelet-Derived Growth Factor Receptor on Endothelial Cells of Multidrug-Resistant Prostate Cancer. JNCI Journal of the National Cancer Institute. 98(11). 783–793. 75 indexed citations

18.

Kim, Sun-Jin, Hisanori Uehara, Sertaç Yazıcı, et al.. (2005). Modulation of Bone Microenvironment with Zoledronate Enhances the Therapeutic Effects of STI571 and Paclitaxel against Experimental Bone Metastasis of Human Prostate Cancer. Cancer Research. 65(9). 3707–3715. 49 indexed citations

19.

Yokoi, Kenji, Sun-Jin Kim, Premal H. Thaker, et al.. (2005). Induction of Apoptosis in Tumor-Associated Endothelial Cells and Therapy of Orthotopic Human Pancreatic Carcinoma in Nude Mice. Neoplasia. 7(7). 696–704. 27 indexed citations

20.

Langley, Robert R., Dominic Fan, Rachel Tsan, et al.. (2004). Activation of the Platelet-Derived Growth Factor-Receptor Enhances Survival of Murine Bone Endothelial Cells. Cancer Research. 64(11). 3727–3730. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact